Tianjin Chase Sun PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Tianjin Chase Sun PharmaceuticalLtd has a total shareholder equity of CN¥9.0B and total debt of CN¥803.8M, which brings its debt-to-equity ratio to 9%. Its total assets and total liabilities are CN¥11.4B and CN¥2.4B respectively. Tianjin Chase Sun PharmaceuticalLtd's EBIT is CN¥171.9M making its interest coverage ratio 5. It has cash and short-term investments of CN¥1.1B.
Key information
9.0%
Debt to equity ratio
CN¥803.83m
Debt
| Interest coverage ratio | 5x |
| Cash | CN¥1.12b |
| Equity | CN¥8.96b |
| Total liabilities | CN¥2.41b |
| Total assets | CN¥11.37b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300026's short term assets (CN¥6.3B) exceed its short term liabilities (CN¥1.7B).
Long Term Liabilities: 300026's short term assets (CN¥6.3B) exceed its long term liabilities (CN¥741.8M).
Debt to Equity History and Analysis
Debt Level: 300026 has more cash than its total debt.
Reducing Debt: 300026's debt to equity ratio has increased from 3.4% to 9% over the past 5 years.
Debt Coverage: 300026's debt is well covered by operating cash flow (129.7%).
Interest Coverage: 300026's interest payments on its debt are well covered by EBIT (5x coverage).